Literature DB >> 2442515

Vascular versus myocardial selectivity of calcium antagonists studied by concentration-time-effect relations.

B Ljung, A Kjellstedt, B Orebäck.   

Abstract

The vascular versus myocardial selectivity of three structurally different calcium antagonists, felodipine, diltiazem, and verapamil, was studied in vitro. The model used was an isolated portal vein preparation and a paced (3 Hz) papillary muscle of the left ventricle of the rat, examined in the same organ bath. In previous experiments with the same tissues, used for screening and eventual selection of felodipine, it was found that the selectivity factors ranged as follows: felodipine much greater than nifedipine greater than diltiazem greater than verapamil = La3+. Since the effect of organic calcium antagonists is slow in onset, the present experiments were designed to determine the inhibitory potencies and the selectivity factor at equilibrium. This was possible by a computer-assisted collection of contractile force measurements and subsequent analysis of the results. In each experiment, one concentration only of one of the three calcium antagonists was given. The time-effect relation was determined for both tissues. After all experiments with a particular drug, when several concentrations had been administered, the hyperbolic concentration-effect relation was determined at various times of exposure. The ensuing pIC50 values, as related to time, for the vascular and the myocardial preparations, described by monoexponential curves and the corresponding potency values (pIC50), could be determined at equilibrium (t = infinity). It was concluded that the vascular over myocardial inhibitory selectivity was marked for felodipine (103), low for diltiazem (8.9), and none for verapamil (0.92).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442515     DOI: 10.1097/00005344-198710001-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  Ambulatory blood pressure monitoring during sustained treatment with conventional and extended-release felodipine in mild-to-moderate hypertension.

Authors:  C Porcellati; P Verdecchia; C Gatteschi; G Benemio; M Guerrieri; F Boldrini; G Pollavini
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Positive inotropic effects of calcium channel antagonists are not necessarily caused by partial calcium channel agonism.

Authors:  N C Punt; F T van Amsterdam; M M Goddijn; M Haas; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

Review 3.  Pharmacodynamic properties of felodipine.

Authors:  B Ljung; M Nordlander
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.

Authors:  B Silke; E Goldhammer; S K Sharma; S P Verma; S H Taylor
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

5.  Effects of extracellular K+ and Ca2+ on membrane potential, contraction and 86Rb+ efflux in guinea-pig mesotubarium.

Authors:  M L Lydrup; P Hellstrand
Journal:  Pflugers Arch       Date:  1990-03       Impact factor: 3.657

6.  The efficacy and tolerability of long-term felodipine treatment in hypertension. The Scandinavian Multicenter Group.

Authors:  H Ibsen; B Westberg
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

7.  Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension.

Authors:  W Koenig; M Sund; L Binner; R Hehr; J Rosenthal; V Hombach
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.